We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

960 hedge funds and large institutions have $45.5B invested in Thermo Fisher Scientific in 2014 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 346 increasing their positions, 368 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more first-time investments, than exits

New positions opened: 111 | Existing positions closed: 58

36% more call options, than puts

Call options by funds: $195M | Put options by funds: $143M

5% more funds holding

Funds holding: 917960 (+43)

3% more capital invested

Capital invested by funds: $44.1B → $45.5B (+$1.41B)

0% more funds holding in top 10

Funds holding in top 10: 6767 (0)

0% less ownership

Funds ownership: 90.96%90.96% (-0%)

6% less repeat investments, than reductions

Existing positions increased: 346 | Existing positions reduced: 368

Holders
960
Holders Change
+43
Holders Change %
+4.69%
% of All Funds
25.6%
Holding in Top 10
67
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
1.79%
New
111
Increased
346
Reduced
368
Closed
58
Calls
$195M
Puts
$143M
Net Calls
+$51.9M
Net Calls Change
-$22.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Asset Management One
276
Asset Management One
Japan
$11.5M +$649K +5,334 +6%
SCM
277
Stevens Capital Management
Pennsylvania
$11.1M +$10.8M +88,617 New
PAM
278
Premier Asset Management
Illinois
$11.1M +$10.7M +88,295 New
RC
279
RegentAtlantic Capital
New Jersey
$10.8M -$80.3K -660 -0.8%
VAM
280
Visium Asset Management
New York
$10.8M +$3.06M +25,154 +41%
LIM
281
Lathrop Investment Management
Arkansas
$10.7M +$74.2K +610 +0.7%
WSFS
282
Wilmington Savings Fund Society
Delaware
$10.5M +$4.04M +33,240 +66%
ProShare Advisors
283
ProShare Advisors
Maryland
$10.2M +$1.63M +13,384 +20%
Calamos Advisors
284
Calamos Advisors
Illinois
$10.2M +$51.3K +422 +0.5%
IGIM
285
I.G. Investment Management
Manitoba, Canada
$10M -$644K -5,298 -6%
GF
286
Gabelli Funds
New York
$10M +$3.65M +30,000 +60%
GT
287
Glenmede Trust
Pennsylvania
$9.9M +$230K +1,895 +2%
CCM
288
Cohen Capital Management
California
$9.87M +$15.2K +125 +0.2%
OPCM
289
Osborne Partners Capital Management
California
$9.82M +$191K +1,570 +2%
LBC
290
Lowe Brockenbrough & Co
Virginia
$9.79M -$336K -2,760 -3%
BPCE
291
Bank Pictet & Cie (Europe)
Germany
$9.75M +$1.44M +11,830 +18%
AIA
292
AGF Investments America
Ontario, Canada
$9.63M
SCI
293
Seneca Capital Investments
New York
$9.51M -$1.46M -12,000 -14%
PI
294
Placemark Investments
Illinois
$9.47M -$365K -3,005 -4%
AAM
295
Aureus Asset Management
Massachusetts
$9.4M +$1.28M +10,490 +16%
DM
296
Delphi Management
Massachusetts
$9.38M -$533K -4,387 -6%
LCS
297
Levin Capital Strategies
New York
$9.34M -$540K -4,438 -6%
EBSAM
298
Eubel Brady & Suttman Asset Management
Ohio
$9.15M -$333K -2,737 -4%
COPPSERS
299
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$9.14M -$21.3K -175 -0.2%
EMR
300
Errol M. Rudman
$9.02M +$2.43M +20,000 +38%

TMO Hedge Fund Activity: Q4 2014 in Review

960 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2014, worth a combined $45.5B — up 3.2% from $44.1B a quarter earlier.

Buyers outnumbered sellers: 111 funds opened new TMO positions and 58 closed out — a net gain of 53 holders — while 346 added to existing stakes and 368 trimmed.

The largest buyer was Capital World Investors, adding an estimated $393M. The largest seller was Viking Global Investors, cutting an estimated $266M.

  • 960 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2014, up from 917 in Q3 2014.
  • Funds reported $45.5B of Thermo Fisher Scientific stock for Q4 2014, up 3.2% quarter-over-quarter.
  • 111 funds opened new Thermo Fisher Scientific positions in Q4 2014 and 58 closed out, a net change of +53 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2014 was Capital World Investors, an estimated $393M added.
  • The largest Thermo Fisher Scientific seller in Q4 2014 was Viking Global Investors, an estimated $266M sold.

Based on aggregated 13F filings for Q4 2014.